SPECIAL NOTICE
We are working on upgrading our websites and despite our best endeavours have experienced census type calamities for almost a week now. Our apologies, we hope to have all problems resolved by Monday August 15th.
Find any Australian or New Zealand company or fund (dead or alive) by using SEARCH above or go directly to the site:
| FROM | TO | |
| MMJ GROUP HOLDINGS LIMITED | 23/10/2018 | |
| MMJ PHYTOTECH LIMITED | 31/07/2015 | 23/10/2018 |
| PHYTOTECH MEDICAL LIMITED | 31/07/2015 |
Automic Registry Services Level 5 126 Phillip Street Sydney NSW 2000
Tel : +61 (2) 8072 1400 or 1300 288 664 (within Australia)The suspension of trading in the securities of MMJ Group Holdings Ltd ("˜MMJ') will be lifted immediately, following the release by MMJ of an announcement regarding its suspension and planned share purchase plan | 19/12/2018 |
The company notes that its shares were placed into suspension by the Australian Securities Exchange ("ASX") on 13 December 2018 pending the result of further enquiries by the ASX regarding MMJ's cash position and capital raising intentions. | 19/12/2018 |
The company's net tangible assets per share as at 30 November 2018 was 22.34 cents (pre-tax) and 21.32 cents (post-tax). | 14/12/2018 |
The securities of MMJ Group Holdings Limited will be suspended from quotation immediately under Listing Rule 17.3, pending response to ASX queries. | 12/12/2018 |
The suspension of trading in the securities of MMJ Group Holdings Limited will be lifted from the commencement of trading tomorrow, Thursday, 22 November 2018. | 21/11/2018 |
The securities of MMJ Group Holdings Limited were reinstated to official quotation today in error. All trades today in the securities of MMJ will be cancelled and the order book purged. Trading in the securities of MMJ will resume from the commencement of trading tomorrow, Thursday, 22 November 2018. | 21/11/2018 |
The securities of MMJ Group Holdings Limited will be reinstated to Official Quotation at the commencement of trading at 10:04:30am AEDT (+/- 15 seconds) as part of Group 3 on Thursday, 22 November 2018, following its re-compliance with Chapters 1 and 2 of the ASX Listing Rules. | 20/11/2018 |
MediPharm Labs Inc has entered into a 3-year cannabis concentrate program agreement with Supreme Cannabis Company Inc. | 15/11/2018 |
Harvest One Cannabis has entered into a multi-year cannabis extraction services agreement with Valens GroWorks Corp. MMJ owns 47.7 million shares in Harvest One for an approximate 27% shareholding. | 15/11/2018 |
MediPharm Labs has been issued a sales licence by Health Canada. MMJ owns 5.2 million shares and 2.9 million warrants (exercisable at CAD$1.20 per share by October 2020) in MediPharm Labs. | 13/11/2018 |
The company has invested CAD$2.5 million of equity into privately-held Embark Health Inc. This increases MMJ's total investment in Embark to CAD$2.65 million for a basic shareholding of circa 10%. | 12/11/2018 |
The company has made a cornerstone equity investment of USD$1 million for an 18.2% shareholding in privately-held VitaGenne Inc. | 08/11/2018 |
The company releases a copy of the news release by MediPharm Labs confirming achievement of the significant milestone of the purification and production of 150,000 grams of cannabis extract. MMJ owns 5.2 million shares and 2.9 million warrants (exercisable at CAD$1.20 per share by October 2020) in MediPharm Labs. | 08/11/2018 |
The company releases an announcement confirming that Fire & Flower Inc. has raised CAD$36.5 million, above its original target of CAD$30 million, from equity instruments ahead of its proposed listing on the TSX Venture Exchange. | 05/11/2018 |
The company has lodged a notice with the TSX Venture Exchange stating its intention to divest up to 5 million of its 48.333 million* shares held in Harvest One Cannabis. | 01/11/2018 |
The company releases a notice of AGM. The meeting will be held at 2:30pm (AEDT) on Wednesday 28 November 2018 at The Westin Sydney 1 Martin Place Sydney, NSW 2000 Australia. | 29/10/2018 |
The company lodges its Annual Report to shareholders. | 29/10/2018 |
The company releases a copy of the management discussion and analysis for the financial year ended 30 June 2018 recently released by Harvest One Cannabis Inc. | 29/10/2018 |
The company lodges its Appendix 4C - quarterly. | 29/10/2018 |
The company has divested 5 million of its 53.333 million shares held in Harvest One Cannabis Inc. through an on-market sale. The intention to make this divestment was first announced by MMJ on 12 October 2018. Including the proceeds of this divestment, MMJ's unaudited corporate cash balance is approximately AUD$5.6 million. MMJ now owns 48.333 million* shares in Harvest One for an approximate 28% shareholding. | 26/10/2018 |
The company releases an announcement by Bod Australia Limited confirming that they have entered into a collaboration agreement with Cannabis Access Clinics. MMJ has AUD$1 million invested in Cannabis Access Clinics for a 17.4% shareholding. | 25/10/2018 |
The company releases an announcement by Harvest One Cannabis Inc confirming the appointment of Will Stewart as its Senior Vice President, Corporate and Public Affairs. MMJ is the largest single shareholder in Harvest One. | 24/10/2018 |
The company releases MediPharm Labs' Management Presentation. | 23/10/2018 |
name changed from MMJ Phytotech Limited | 23/10/2018 |
The suspension of trading in the securities of MMJ Group Holdings Ltd ("˜MMJ') will be lifted immediately, following the release by MMJ of an announcement regarding its suspension and planned share purchase plan | 19/12/2018 |
The company notes that its shares were placed into suspension by the Australian Securities Exchange ("ASX") on 13 December 2018 pending the result of further enquiries by the ASX regarding MMJ's cash position and capital raising intentions. | 19/12/2018 |
The company's net tangible assets per share as at 30 November 2018 was 22.34 cents (pre-tax) and 21.32 cents (post-tax). | 14/12/2018 |
The securities of MMJ Group Holdings Limited will be suspended from quotation immediately under Listing Rule 17.3, pending response to ASX queries. | 12/12/2018 |
The suspension of trading in the securities of MMJ Group Holdings Limited will be lifted from the commencement of trading tomorrow, Thursday, 22 November 2018. | 21/11/2018 |
The securities of MMJ Group Holdings Limited were reinstated to official quotation today in error. All trades today in the securities of MMJ will be cancelled and the order book purged. Trading in the securities of MMJ will resume from the commencement of trading tomorrow, Thursday, 22 November 2018. | 21/11/2018 |
The securities of MMJ Group Holdings Limited will be reinstated to Official Quotation at the commencement of trading at 10:04:30am AEDT (+/- 15 seconds) as part of Group 3 on Thursday, 22 November 2018, following its re-compliance with Chapters 1 and 2 of the ASX Listing Rules. | 20/11/2018 |
MediPharm Labs Inc has entered into a 3-year cannabis concentrate program agreement with Supreme Cannabis Company Inc. | 15/11/2018 |
Harvest One Cannabis has entered into a multi-year cannabis extraction services agreement with Valens GroWorks Corp. MMJ owns 47.7 million shares in Harvest One for an approximate 27% shareholding. | 15/11/2018 |
MediPharm Labs has been issued a sales licence by Health Canada. MMJ owns 5.2 million shares and 2.9 million warrants (exercisable at CAD$1.20 per share by October 2020) in MediPharm Labs. | 13/11/2018 |
The company has invested CAD$2.5 million of equity into privately-held Embark Health Inc. This increases MMJ's total investment in Embark to CAD$2.65 million for a basic shareholding of circa 10%. | 12/11/2018 |
The company has made a cornerstone equity investment of USD$1 million for an 18.2% shareholding in privately-held VitaGenne Inc. | 08/11/2018 |
The company releases a copy of the news release by MediPharm Labs confirming achievement of the significant milestone of the purification and production of 150,000 grams of cannabis extract. MMJ owns 5.2 million shares and 2.9 million warrants (exercisable at CAD$1.20 per share by October 2020) in MediPharm Labs. | 08/11/2018 |
The company releases an announcement confirming that Fire & Flower Inc. has raised CAD$36.5 million, above its original target of CAD$30 million, from equity instruments ahead of its proposed listing on the TSX Venture Exchange. | 05/11/2018 |
The company has lodged a notice with the TSX Venture Exchange stating its intention to divest up to 5 million of its 48.333 million* shares held in Harvest One Cannabis. | 01/11/2018 |
The company releases a notice of AGM. The meeting will be held at 2:30pm (AEDT) on Wednesday 28 November 2018 at The Westin Sydney 1 Martin Place Sydney, NSW 2000 Australia. | 29/10/2018 |
The company lodges its Annual Report to shareholders. | 29/10/2018 |
The company releases a copy of the management discussion and analysis for the financial year ended 30 June 2018 recently released by Harvest One Cannabis Inc. | 29/10/2018 |
The company lodges its Appendix 4C - quarterly. | 29/10/2018 |
The company has divested 5 million of its 53.333 million shares held in Harvest One Cannabis Inc. through an on-market sale. The intention to make this divestment was first announced by MMJ on 12 October 2018. Including the proceeds of this divestment, MMJ's unaudited corporate cash balance is approximately AUD$5.6 million. MMJ now owns 48.333 million* shares in Harvest One for an approximate 28% shareholding. | 26/10/2018 |
The company releases an announcement by Bod Australia Limited confirming that they have entered into a collaboration agreement with Cannabis Access Clinics. MMJ has AUD$1 million invested in Cannabis Access Clinics for a 17.4% shareholding. | 25/10/2018 |
The company releases an announcement by Harvest One Cannabis Inc confirming the appointment of Will Stewart as its Senior Vice President, Corporate and Public Affairs. MMJ is the largest single shareholder in Harvest One. | 24/10/2018 |
The company releases MediPharm Labs' Management Presentation. | 23/10/2018 |
name changed from MMJ Phytotech Limited | 23/10/2018 |
Your browser may reflect a date of printing in American format.
Purchases Sales
| DATE | DIRECTOR | NUMBER | PRICE | AMOUNT |
|---|---|---|---|---|
| 24/04/2019 | Doug Halley | 63,000 | $0.235 | $14,804 |
| 18/04/2019 | Doug Halley | 137,000 | $0.240 | $32,880 |
| 11/10/2016 | Peter Wall | 100,000 | $0.230 | $23,000 |
| NAME | TITLE | DATE OF APPT |
|---|---|---|
| Peter Wall | Non Exec Chairman | 01/03/2012 |
| Catherine Harvey | COO | 01/09/2016 |
| Jim Hallam | CFO | 03/04/2018 |
| Winton Willesse | Non Exec Director | |
| Doug Halley | Non Exec Director | 16/03/2018 |
| Michael Curtis | Non Exec Director | 08/01/2019 |
Date of first appointment, title may have changed.
| NAME | TITLE | DATE OF APPOINTMENT | DATE OF RESIGNATION |
|---|---|---|---|
| Jason Conroy | CEO | 26/02/2018 | 01/03/2019 |
| Lisa Dea | CFO | 14/06/2017 | 03/04/2018 |
| Jason Bednar | Non Exec Director | 16/03/2018 | |
| Andreas Gedeon | Managing Director, CEO | 27/07/2015 | 26/02/2018 |
| Richard Jarvis | CFO | 04/07/2016 | 14/06/2017 |
| Ross McKay | Non Exec Director | 11/08/2016 | |
| Benad Goldwasser | Non Exec Director | 27/01/2015 | 20/08/2015 |
| Boaz Wachtel | Executive Director | 20/08/2015 | |
| Ross Smith | Director | 02/02/2015 |
Date of first appointment, title may have changed.
Contact Us | Financial Services Guide
This website is owned and operated by Investogain Pty Limited.
ABN 88 129 443 447 | AFSL 334036
Information provided is of a general nature and not for trading or advice.
Copyright © 2002-2020 Investogain Pty Limited. All rights reserved.
